SBFM · Sunshine Biopharma Inc.
$1.67
-0.04 (-2.34%)
At close · Jul 24
Market Cap
$8.31M
Shares
5.01M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-04-14 | NATAN DAVID |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a stock award to the reporting person. |
Common Stock
|
100,000 |
| 2024-03-04 | Slilaty Steve N. |
Director, Chief Executive Officer, 10% Owner |
Buy↑
|
Series B Preferred Stock
|
100,000 |
| 2024-02-08 | Slilaty Steve N. |
Director, Chief Executive Officer, 10% Owner |
Buy↑
|
Series B Preferred Stock
|
20,000 |
| 2024-01-26 | Beaudoin Marc |
Chief Operating Officer |
Other↑
|
No Securities Owned
|
0 |
| 2022-11-30 | Sebaaly Camille |
CFO/Secretary |
Buy↑
|
Common Stock
|
30,000 |
| 2022-06-03 | Sebaaly Camille |
CFO/Secretary |
Buy↑
|
Common Stock
|
25,000 |
| 2022-02-18 | Slilaty Steve N. |
Director, Chief Executive Officer, 10% Owner |
Other↓
Filing footnotes — Series B Preferred Stock (Direct)
Dr. Slilaty returned 990,000 shares of Series B Preferred Stock to the Issuer for a redemption price equal to the stated value of $0.10 per share. |
Series B Preferred Stock
|
990,000 |
| 2021-01-06 | MERZOUKI ABDERRAZZAK |
Director, Chief Operating Officer |
Award↑
|
Common Stock
|
20,000,000 |
| 2021-01-06 | Slilaty Steve N. |
Director, Chief Executive Officer, 10% Owner |
Award↑
|
Common Stock
|
20,000,000 |
| 2021-01-06 | Sebaaly Camille |
CFO/Secretary |
Award↑
|
Common Stock
|
20,000,000 |
| 2020-06-17 | Slilaty Steve N. |
Director, Chief Executive Officer, 10% Owner |
Award↑
|
Series "B" Preferred Stock
|
500,000 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–11 of 11 transactions